In patients with insulin resistance, the adipokines resistin, leptin, PAI-1, and retinol binding protein 4 (RBP4) can dysregulate the insulin receptor substrate-1 (IRS-1) level in megakaryocytes, thus disrupting insulin signaling in platelets [49,50]. The gene discussed is RBP4; the disease is Insulin resistance.